AI is speeding up the search for new medicines. Can it make the discoveries themselves?
Few people are better placed to answer that than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don't exist in nature, and he is now vice chairman and president of its parent company, OPKO Health.
On the latest episode of KFF's The Business of Health, I sit down with Dr. Zerhouni to dig into what AI is actually doing in drug development, how the FDA stacks up against regulators abroad, and what a slowdown in AI could mean for the next generation of cures.
Listen to the latest episode of my podcast: https://t.co/QjEgvELYuP
Most hospitals buy their AI. Charité – Universitätsmedizin Berlin, Europe’s largest academic medical center and ranked eighth in the world by Newsweek, is developing its own.
On the latest episode of KFF's The Business of Health, I sit down with Prof. Dr. Heyo Kroemer, Chief Executive Officer of Charité – Universitätsmedizin Berlin, to discuss what Charité stands to gain or lose by taking this path, and what it means to own an AI platform rather than license one.
Listen to the latest episode of my podcast: https://t.co/2TIT1cVd7c
HIPAA is 30. Most people think the “P” stands for privacy. It stands for portability. In @Health_Affairs Forefront, Chris Jennings and I look at what the law actually built and why it can still serve health care’s future. https://t.co/grw13oasRM
I was on the Ways and Means health staff when HIPAA passed in 1996. Thirty years later, most people still think the “P” means privacy. It means portability. My @Health_Affairs piece on what HIPAA built and why it still matters: https://t.co/grw13ob0Hk
Hot off the press in Health Affairs Forefront: my new piece, “Buy Right: Key Choices To Getting Value-Based Payment Right.”
Congress should move beyond today’s fragmented, program-by-program approach to value-based purchasing and establish a unified, all-payer platform: consistently defined and risk-adjusted measures of expected clinical and patient-reported outcomes.
https://t.co/W5BuZhgEaV
Hot off the press in Health Affairs Forefront: my new piece, “Buy Right: Key Choices To Getting Value-Based Payment Right.”Congress should replace today’s fragmented, program-by-program approach to value-based purchasing with a unified, all-payer platform for consistently defined and risk-adjusted clinical and patient-reported outcomes.https://t.co/W5BuZhgEaV
This week, @ChipKahn and @UCSFMedicine’s @Bob_Wachter discuss whether AI will produce a different kind of doctor in the future — a “clinician curator rather than a clinician-diagnostician.”
The answer could define the future of medicine and the doctor-patient relationship: https://t.co/EEfZPbnuEl
I interviewed John Halamka, President of the Mayo Clinic Platform, about whether AI is disruptive or just more incremental change.
Spoiler alert: His experiences show it’s disruptive, in a good way, for empowering providers and patients.
Link to listen: https://t.co/e3sbFmGmDF
How could the couple in that year have shown a picture of their interaction with the President 20 miles down the road? They would had to have the film from the camera developed and at that time there is no way that would have even been same day. I guess they could have had the developing instruments in their car trunk but that is unlikely. So does that bring into question the whole story?
The AI revolution is already here — but what does it mean for patients, clinicians, and health care industry leaders?
Listen to the latest episode of my new podcast, @KFF’s Business of Health: https://t.co/7IYpWb2zdR
These days, if I’m not behind a camera taking photographs, I’m behind a mic interviewing guests for my new podcast at KFF, focusing first on the key issue of how AI is changing health care.
Subscribe wherever you get podcasts. https://t.co/OYbfYOOLmV
New podcast alert: KFF’s Drew Altman and I explore how the business of health is evolving and what it means for all of us in the very first episode of KFF’s Business of Health with Chip Kahn.
Have you listened yet? I’d love to know what you think. https://t.co/BtPACH7X5m